Mineralys CCO Eric Warren Executes $199K Sale Under Pre-Approved Plan
Eric Warren, the Chief Commercial Officer at Mineralys Therapeutics, Inc. (NASDAQ: MLYS), executed a sale of 7,438 shares of the company's common stock on July 21, 2026. The transaction, valued at approximately $199,885, was conducted under a Rule 10b5-1 trading plan established in March 2026. This sale follows the exercise of stock options on the …